Partial loading of the left ventricle during mechanical assist device support is associated with improved myocardial function, blood flow and metabolism and increased exercise capacity

Journal of Heart and Lung Transplantation

Volumn 21, Issue 4, 2002, Pages 446-454

  Maybaum, Simon ^a,b   Epstein, Shilpi ^a   Beniaminovitz, Ainat ^a   Di Tullio, Marco ^a   Oz, Mehmet ^a   Bergmann, Steven R ^a   Mancini, Donna ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Heart Failure Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEVICE; EXERCISE TEST; FEMALE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART OUTPUT; HEART WORK; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; BLOOD FLOW VELOCITY; CORONARY CIRCULATION; ECHOCARDIOGRAPHY, DOPPLER; EQUIPMENT SAFETY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; OXYGEN CONSUMPTION; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036131260     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(01)00392-8     Document Type: Article

References (36)

1. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading
2. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure
3. Regression of cellular hypertrophy after left ventricular assist device support
4. The effect of prolonged left ventricular assist device support on myocardial histopathology in patients with end-stage cardiomyopathy
5. The effect of sustained mechanical support with left ventricular assist devices on myocardial apoptosis in patients with severe dilated cardiomyopathy
6. Left ventricular echocardiographic and histologic changes; impact of chronic unloading by an implantable ventricular assist device
7. Structural and left ventricular histological changes after implantable LVAD insertion
8. Improved left ventricular function after chronic left ventricular unloading
9. LVAD therapy improves myocardial mitochondrial metabolism in patients with heart failure
10. Potential for left ventricular assist devices as out-patient therapy while awaiting transplantation
11. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy
12. Acute fulminant myocarditis; long-term follow-up after circulatory support with left ventricular assist device
13. Case report; circulatory support for seventy days with resolution of acute heart failure
14. Temporary left-sided mechanical cardiac support during acute myocarditis
15. Management of acute fulminant myocarditis using circulatory support systems
16. Left ventricular assist system as a bridge to myocardial recovery
17. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure
18. Weaning from mechanical support in patients with dilated cardiomyopathy
19. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device
20. Directions in cardiac assistance
21. Cardiac disuse atrophy during LVAD pumping
22. Measurement of regional myocardial blood flow with N-13 ammonia and positron emission tomography in intact dogs
23. Quantification of regional myocardial blood flow using N-13 ammonia and reoriented dynamic positron emission tomographic imaging
24. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization
25. Delineation of myocardial oxygen utilization with carbon-11 labeled acetate
26. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography
27. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction
28. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate
29. Implantable left ventricular assist devices
30. Time course of left ventricular mass regression following left ventricular assist device implantation
31. Atrophy of myocardium and its myocytes by left ventricular assist device
32. Influence of prolonged ventricular assistance on myocardial histopathology in intact heart
33. Evolution of human cardiac myocyte dimension during prolonged mechanical support
34. The time course of reverse structural remodeling of the left ventricle during LVAD support
35. Inflow valve regurgitation during left ventricular assist device support may interfere with reverse ventricular remodeling
36. Assessment of synchrony relationships between the native cardiac cycle and the TCI left ventricular assist device